Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DRP2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BMP1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | TBC1D28 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TRAPPC9 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | FAM168B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | LRRC25 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TSSK4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | HNRNPA0 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | AATK-AS1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ZNF266 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |